We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Celsius Holdings
CELH
$7.29B
| $2.98M | 0.01% |
59,952
+41,454
| +224% | +$1.65M |
|
827
Exelixis
EXEL
$14.3B
| $2.96M | 0.01% |
155,031
-4,186
| -3% | -$80.7K |
|
828
Alector
ALEC
$222M
| $2.93M | 0.01% |
487,734
-2,260,419
| -82% | -$15.8M |
|
829
Apogee Enterprises
APOG
$788M
| $2.93M | 0.01% |
61,694
-5,410
| -8% | -$226K |
|
830
Gray Television
GTN
$493M
| $2.93M | 0.01% |
+371,239
| New | +$2.85M |
|
831
TripAdvisor
TRIP
$1.05B
| $2.92M | 0.01% |
177,377
+121,593
| +218% | +$2.06M |
|
832
Nice
NICE
$6.12B
| $2.92M | 0.01% |
14,123
+3,270
| +30% | +$674K |
|
|
SUM
833
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.91M | 0.01% |
76,985
+22,073
| +40% | +$683K |
|
834
Altria Group
MO
$118B
| $2.91M | 0.01% |
64,254
+4,592
| +8% | +$208K |
|
|
WNS
835
DELISTED
WNS Holdings
WNS
| $2.9M | 0.01% |
39,288
-31,749
| -45% | -$2.54M |
|
|
CTLP
836
DELISTED
Cantaloupe
CTLP
| $2.89M | 0.01% |
363,303
-6,782
| -2% | -$43.9K |
|
|
VMEO
837
DELISTED
Vimeo
VMEO
| $2.88M | 0.01% |
699,035
-107,352
| -13% | -$406K |
|
838
LegalZoom.com
LZ
$1.06B
| $2.88M | 0.01% |
238,008
+219,428
| +1,181% | +$2.32M |
|
839
Oneok
OKE
$59B
| $2.87M | 0.01% |
46,564
+41,968
| +913% | +$2.6M |
|
840
EnerSys
ENS
$6.25B
| $2.85M | 0.01% |
26,292
+7,748
| +42% | +$707K |
|
841
Hanover Insurance
THG
$8.12B
| $2.85M | 0.01% |
25,233
+3,880
| +18% | +$460K |
|
842
CACI
CACI
$14.1B
| $2.84M | 0.01% |
8,330
-845
| -9% | -$262K |
|
843
Century Communities
CCS
$1.75B
| $2.84M | 0.01% |
+37,045
| New | +$2.48M |
|
|
HCCI
844
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $2.83M | 0.01% |
74,785
-29,103
| -28% | -$1.02M |
|
845
Pinterest
PINS
$10.6B
| $2.82M | 0.01% |
103,100
+102,292
| +12,660% | +$2.55M |
|
846
Waterstone Financial
WSBF
$381M
| $2.81M | 0.01% |
193,913
-214
| -0.1% | -$3.06K |
|
|
NVRO
847
DELISTED
NEVRO CORP.
NVRO
| $2.8M | 0.01% |
110,324
-448,694
| -80% | -$13M |
|
848
NiSource
NI
$19.5B
| $2.77M | 0.01% |
101,251
+40,336
| +66% | +$1.12M |
|
849
Antero Resources
AR
$11.3B
| $2.76M | 0.01% |
119,839
+79,548
| +197% | +$1.77M |
|
850
Biohaven
BHVN
$1.82B
| $2.76M | 0.01% |
115,194
+109,001
| +1,760% | +$1.88M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.